Inside the Technology of the Syantra DX Breast Cancer Test

Dr. Kristina Rinker, PhD, and Dr. Kenneth Fuh, PhD, from Syantra Inc., share insights into the groundbreaking technology behind the Syantra DX Breast Cancer Test.
This innovative blood-based test can detect early-stage breast cancer, including small tumors, potentially increasing survival rates through earlier detection. Syantra Inc. is committed to expanding clinical data to better understand how the test performs across women from diverse social and racial backgrounds, enhancing its impact on breast cancer screening worldwide.